Near-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer

[1]  M. M. Trachez,et al.  COMPARATIVE EFFECTS OF TRAMADOL ON VASCULAR REACTIVITY IN NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RATS , 2008, Clinical and experimental pharmacology & physiology.

[2]  J. Brockmöller,et al.  Effects of the CYP2D6 Gene Duplication on the Pharmacokinetics and Pharmacodynamics of Tramadol , 2008, Journal of clinical psychopharmacology.

[3]  A. Hoeft,et al.  Concentrations of Tramadol and O‐desmethyltramadol Enantiomers in Different CYP2D6 Genotypes , 2007, Clinical pharmacology and therapeutics.

[4]  M. A. Campanero,et al.  Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype. , 2007, Pharmacological research.

[5]  P. Charbonneau,et al.  Refractory shock and asystole related to tramadol overdose , 2007, Clinical toxicology.

[6]  R. Walsky,et al.  Evaluation of 227 Drugs for In Vitro Inhibition of Cytochrome P450 2B6 , 2006, Journal of clinical pharmacology.

[7]  J. Pascussi,et al.  Ketoconazole and Miconazole Are Antagonists of the Human Glucocorticoid Receptor: Consequences on the Expression and Function of the Constitutive Androstane Receptor and the Pregnane X Receptor , 2006, Molecular Pharmacology.

[8]  K. Brøsen,et al.  Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers , 2006, European Journal of Clinical Pharmacology.

[9]  M. M. Trachez,et al.  In vitro and in vivo vasodilator activity of racemic tramadol and its enantiomers in Wistar rats. , 2006, European journal of pharmacology.

[10]  Garrett Pm.  Tramadol overdose and serotonin syndrome manifesting as acute right heart dysfunction. , 2004 .

[11]  P. Garrett.  Tramadol Overdose and Serotonin Syndrome Manifesting as Acute Right Heart Dysfunction , 2004, Anaesthesia and intensive care.

[12]  J. Sasse,et al.  Serotonin syndrome with tramadol and citalopram. , 2004, The American journal of psychiatry.

[13]  D. J. Houlihan.  Serotonin Syndrome Resulting from Coadministration of Tramadol, Venlafaxine, and Mirtazapine , 2004, The Annals of pharmacotherapy.

[14]  S. Grond,et al.  Clinical Pharmacology of Tramadol , 2004, Clinical pharmacokinetics.

[15]  M. Eichelbaum,et al.  CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real‐rime PCR , 2003, Human mutation.

[16]  Ilkka Ojanperä,et al.  Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood. , 2003, Forensic science international.

[17]  U. Hofmann,et al.  Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. , 2001, Pharmacogenetics.

[18]  H. Dengler,et al.  PHARMACOKINETICS AND DISPOSITION , 1997 .

[19]  L. Arendt-Nielsen,et al.  The hypoalgesic effect of tramadol in relation to CYP2D6 * , 1996, Clinical pharmacology and therapeutics.

[20]  U. Meyer,et al.  An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis. , 1995, Pharmacogenetics.

[21]  B. Müller,et al.  Cardiac and hemodynamic effects of the centrally acting analgesics tramadol and pentazocine in anaesthetized rabbits and isolated guinea-pig atria and papillary muscles. , 1984, Arzneimittel-Forschung.